Moxalactam FDA Link

Broad- spectrum beta-lactam antibiotic similar in structure to the CEPHALOSPORINS except for the substitution of an oxaazabicyclo moiety for the thiaazabicyclo moiety of certain CEPHALOSPORINS. It has been proposed especially for the meningitides because it passes the blood-brain barrier and for anaerobic infections.

Also Known As:

Latamoxef; Moxalactam Disodium; 6059-S; Disodium Latamoxef; Disodium Moxalactam; Festamoxin; Lamoxactam; Lilly 127935; Ly-127935; Ly127935; S-6059; Shiomarin; 1 Oxacephalosporin; 6059 S; 6059S; Disodium, Moxalactam; Latamoxef, Disodium; Ly 127935; Moxalactam, Disodium; S 6059; S6059; 1-Oxacephalosporin; 5- Oxa- 1- azabicyclo(4.2.0)oct- 2- ene- 2- carboxylic acid, 7- ((carboxy(4- hydroxyphenyl)acetyl)amino)- 7- methoxy- 3- (((1- methyl- 1H- tetrazol- 5- yl)thio)methyl)- 8- oxo-

Pharmalogical Action Categories:

Anti-Bacterial Agents

Organic Chemicals: 133
- Amides: 2428
  - Lactams: 2198
    - beta-Lactams: 2386
      - Moxalactam: 436
- Sulfur Compounds: 278
  - Sulfides: 1062
    - Moxalactam: 436
Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - beta-Lactams: 2386
      - Moxalactam: 436

Moxalactam Products